End-of-day quote
Other stock markets
|
||
- | - |
04-25 | Labcorp beats quarterly estimates on strong testing demand | RE |
04-25 | Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln | RE |
Sales 2021 | 460M 0 36.67B | Sales 2022 | 516M 0 41.12B | Capitalization | 452M 0 35.98B |
---|---|---|---|---|---|
Net income 2021 | -379M - -30.19B | Net income 2022 | -3.11B - -247B | EV / Sales 2021 | 8.98 x |
Net Debt 2021 | 679M 0 54.06B | Net Debt 2022 | 1.2B 0 95.89B | EV / Sales 2022 | 3.21 x |
P/E ratio 2021 |
-8.5
x | P/E ratio 2022 |
-0.14
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 98.19% |
Latest transcript on InVitae Corp
Managers | Title | Age | Since |
---|---|---|---|
Kenneth Knight
CEO | Chief Executive Officer | 63 | 28/06/20 |
Ana Schrank
DFI | Director of Finance/CFO | - | 01/10/23 |
David Sholehvar
COO | Chief Operating Officer | 56 | 11-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 03/11/15 | |
Randal Scott
CEO | Chief Executive Officer | 66 | 12/01/10 |
Eric Aguiar
BRD | Director/Board Member | 62 | 31/08/10 |
1st Jan change | Capi. | |
---|---|---|
-26.34% | 9.87B | |
-12.42% | 2.74B | |
-11.15% | 2.24B | |
-17.56% | 1.63B | |
+59.16% | 1.39B | |
+29.38% | 772M | |
-1.31% | 760M | |
-23.78% | 516M | |
+5.37% | 310M |